Escape from highly effective public CD8+ T-cell clonotypes by HIV

Blood

Volumn 118, Issue 8, 2011, Pages 2138-2149

  Iglesias, Maria Candela ^a   Almeida, Jorge R ^a,b   Fastenackels, Solène ^a   Van Bockel, David J ^c   Hashimoto, Masao ^d   Venturi, Vanessa ^e   Gostick, Emma ^f   Urrutia, Alejandra ^a   Wooldridge, Linda ^f   Clement, Mathew ^f   Gras, Stéphanie ^g   Wilmann, Pascal G ^g   Autran, Brigitte ^a,h   Moris, Arnaud ^a   Rossjohn, Jamie ^g   Davenport, Miles P ^e   Takiguchi, Masafumi ^d   Brander, Christian ^i,j   Douek, Daniel C ^b   Kelleher, Anthony D ^c   Price, David A ^b,f   Appay, Victor A ^a,h   more..

^a SORBONNE UNIVERSITÉ   (France)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d KUMAMOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^g MONASH UNIVERSITY   (Australia)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^j INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA B ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; LYSYLARGINYLTRYPTOPHYLISOLEUCYLISOLEUCYLLEUCYLGLYCYLLEUCYLASPARAGINYLLYSINE; POLYPEPTIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

EID: 80052165671     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-328781     Document Type: Article

References (50)

1. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008;8(4):247-258.
2. Davenport MP, Price DA, McMichael AJ. The T cell repertoire in infection and vaccination: implications for control of persistent viruses. Curr Opin Immunol. 2007;19(3):294-300.
3. Appay V, Douek DC, Price DA. CD8 T cell efficacy in vaccination and disease. Nat Med. 2008;14(6):623-628.
4. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006;6(12):883-894.
5. Venturi V, Price DA, Douek DC, Davenport MP. The molecular basis for public T-cell responses? Nat Rev Immunol. 2008;8(3):231-238.
6. Miles JJ, Douek DC, Price DA. Bias in the αβ T cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol. 2011;89(3):375-387.
7. Price DA, West SM, Betts MR, et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity. 2004;21(6):793-803.
8. Menezes JS, van den Elzen P, Thornes J, et al. A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. J Clin Invest. 2007;117(8):2176-2185.
9. Price DA, Asher TE, Wilson NA, et al. Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J Exp Med. 2009;206(4):923-936.
10. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med. 1996;2(4):405-411.
11. Almeida JR, Price DA, Papagno L, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007;204(10):2473-2485.
12. Feeney ME, Tang Y, Roosevelt KA, et al. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol. 2004;78(16):8927-8930.
13. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic Tlymphocyte response associated with progression to AIDS. Nat Med. 1997;3(2):212-217.
14. Kelleher AD, Long C, Holmes EC, et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med. 2001;193(3):375-386.
15. Price DA, Brenchley JM, Ruff LE, et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med. 2005;202(10):1349-1361.
16. Purbhoo MA, Boulter JM, Price DA, et al. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. J Biol Chem. 2001;276(35):32786-32792.
17. Wooldridge L, Lissina A, Cole DK, van den Berg HA, Price DA, Sewell AK. Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology. 2009;126(2):147-164.
18. Almeida JR, Sauce D, Price DA, et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood. 2009;113(25):6351-6360.
19. Douek DC, Betts MR, Brenchley JM, et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol. 2002;168(6):3099-3104.
20. Saez-Cirion A, Lacabaratz C, Lambotte O, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci U S A. 2007;104(16):6776-6781.
21. Venturi V, Kedzierska K, Price DA, et al. Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination. Proc Natl Acad Sci U S A. 2006;103(49):18691-18696.
22. Venturi V, Chin HY, Asher TE, et al. TCR betachain sharing in human CD8+ T cell responses to cytomegalovirus and EBV. J Immunol. 2008;181(11):7853-7862.
23. Venturi V, Chin HY, Price DA, Douek DC, Davenport MP. The role of production frequency in the sharing of simian immunodeficiency virusspecific CD8+ TCRs between macaques. J Immunol. 2008;181(4):2597-2609.
24. Quigley MF, Greenaway HY, Venturi V, et al. Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. Proc Natl Acad Sci U S A. 2010;107(45):19414-19419.
25. Robins HS, Srivastava SK, Campregher PV, et al. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci Transl Med. 2010;2(47):47ra64.
26. Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol. 1999;162(4):2227-2234.
27. Vingert B, Perez-Patrigeon S, Jeannin P, et al. HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity. PLoS Pathog. 2010;6(2):e1000780.
28. Williams MA, Ravkov EV, Bevan MJ. Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory. Immunity. 2008;28(4):533-545.
29. Laugel B, van den Berg HA, Gostick E, et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem. 2007;282(33):23799- 23810.
30. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med. 1996;2(3):338-342.
31. Lichterfeld M, Kavanagh DG, Williams KL, et al. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med. 2007;204(12):2813-2824.
32. Argaet VP, Schmidt CW, Burrows SR, et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med. 1994;180(6):2335-2340.
33. Cibotti R, Cabaniols JP, Pannetier C, et al. Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J Exp Med. 1994;180(3):861-872.
34. Fazilleau N, Cabaniols JP, Lemaitre F, Motta I, Kourilsky P, Kanellopoulos JM. Valpha and Vbeta public repertoires are highly conserved in terminal deoxynucleotidyl transferase-deficient mice. J Immunol. 2005;174(1):345-355.
35. Lim A, Trautmann L, Peyrat MA, et al. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J Immunol. 2000;165(4):2001-2011.
36. Trautmann L, Rimbert M, Echasserieau K, et al. Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J Immunol. 2005; 175(9):6123-6132.
37. Goulder PJ, Brander C, Tang Y, et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature. 2001;412(6844):334-338.
38. Schneidewind A, Brockman MA, Yang R, et al. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol. 2007;81(22):12382-12393.
39. van Bockel DJ, Price DA, Munier ML, et al. Persistent survival of prevalent clonotypes within an immunodominant HIV Gag-specific CD8+ T-cell response. J Immunol. 2011;186(1):359-371.
40. Schneidewind A, Brumme ZL, Brumme CJ, et al. Transmission and long-term stability of compensated CD8 escape mutations. J Virol. 2009;83(8):3993-3997.
41. Cawthon AG, Kroger CJ, Alexander-Miller MA. High avidity CD8+ T cells generated from CD28-deficient or wildtype mice exhibit a differential dependence on lipid raft integrity for activation. Cell Immunol. 2004;227(2):148-155.
42. Cawthon AG, Lu H, Alexander-Miller MA. Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: correlation with CD8alphabeta versus CD8alphaalpha expression. J Immunol. 2001;167(5):2577-2584.
43. Motozono C, Yanaka S, Tsumoto K, Takiguchi M, Ueno T. Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL. J Immunol. 2009;182(9):5528-5536.
44. Park JH, Adoro S, Lucas PJ, et al. 'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat Immunol. 2007;8(10):1049-1059.
45. Schamel WW, Arechaga I, Risueno RM, et al. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response. J Exp Med. 2005;202(4):493-503.
46. Casartelli N, Guivel-Benhassine F, Bouziat R, Brandler S, Schwartz O, Moris A. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. J Exp Med. 2010;207(1):39-49.
47. Labrecque N, Whitfield LS, Obst R, Waltzinger C, Benoist C, Mathis D. How much TCR does a T cell need? Immunity. 2001;15(1):71-82.
48. Learmont J, Tindall B, Evans L, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet. 1992;340(8824):863-867.
49. Dyer WB, Ogg GS, Demoitie MA, et al. Strong human immunodeficiency virus (HIV)-specific cytotoxic T- lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol. 1999;73(1):436-443.
50. Appay V, Iglesias MC. Antigen sensitivity and T-cell receptor avidity as critical determinants of HIV control. Curr Opin HIV AIDS. 2011;6(3):157-162.